SCHEMBL420849

SCHEMBL420849

Cc1ccccc1S(=O)(=O)NN

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.50
SLC1A2 P43004 1/20 0.50
SLC1A1 P43005 1/20 0.50
ALDH1A1 P00352 3/20 0.49
TP53 P04637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
EDNRA P25101 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
PKM P14618 2/20 0.45
KAT6A Q92794 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
EDNRB P24530 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268095 1.00 SLC1A3 (0.50) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
Water SCHEMBL27947231 0.98 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
Hydrochloric Acid SCHEMBL3649981 0.98 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
SCHEMBL1427884 0.84 CA1 (0.48) CA1CA2CA9KMT2ACA12
SCHEMBL6927887 0.82 EDNRA (0.54) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
SCHEMBL15741869 0.80 ALDH1A1 (0.46) SLC1A3SLC1A2SLC1A1ALDH1A1CA1
SCHEMBL634340 0.80 LMNA (0.57) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
SCHEMBL30338563 0.80 LMNA (0.57) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
SCHEMBL4636106 0.78 CA1 (0.55) SLC1A3SLC1A2SLC1A1ALDH1A1TP53
SCHEMBL10530500 0.78 ALDH1A1 (0.49) SLC1A3SLC1A2SLC1A1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071019-A1 NORBORNENE-DERIVED COPOLYMER, MANUFACTURING METHOD THEREOF AND METHOD FOR USING THE SAME CPC CORP TAIWAN (TW) 2026-03-12 US claimed
CN-118073019-B Intelligent power cable with moistureproof capability and preparation process 广州岭南电缆股份有限公司 2024-06-28 CN claimed
CN-118073019-A Intelligent power cable with moistureproof capability and preparation process 广州岭南电缆股份有限公司 2024-05-24 CN claimed
CN-116162046-A Alkynyl sulfone derivative and preparation method and application thereof 云南民族大学 2023-05-26 CN claimed
EP-4157915-A1 LIQUID FORMULATION COMPRISING AN ALDEHYDE SCAVENGER Ferline SA (CH) 2023-04-05 EP claimed
CN-111689883-B Synthetic method of diaryl sulfone compound 上海应用技术大学 2022-02-11 CN claimed
WO-2021239634-A1 LIQUID FORMULATION COMPRISING AN ALDEHYDE SCAVENGER REPI S.R.L. (IT) 2021-12-02 WO claimed
CN-111689883-A Synthetic method of diaryl sulfone compound 上海应用技术大学 2020-09-22 CN claimed
CN-110078772-A Fluorescence probe based on complex of iridium and preparation method thereof and the application in hypochlorous acid detects 福州大学 2019-08-02 CN claimed
CN-109722241-A A kind of identification copper ion and the difunctional fluorescence probe of mercury ion and its preparation method and application 东北农业大学 2019-05-07 CN claimed
US-20050004167-A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases WARNER-LAMBERT COMPANY LLC 2005-01-06 US claimed
EP-1472259-A1 TETRAPYRROLIC MACROCYCLES AS PHOTODYNAMIC AGENTS CIPAN-Companhia Industrial Produtora De Antibioticos, S.A. (PT) 2004-11-03 EP claimed
WO-2003089921-A1 METHODS FOR SEPARATION AND DETECTION OF KETOSTEROIDS AND OTHER CARBONYL-CONTAINING COMPOUNDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-10-30 WO claimed
WO-2003064427-A1 TETRAPYRROLIC MACROCYCLES AS PHOTODYNAMIC AGENTS CIPAN - COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS, S.A. (PT) 2003-08-07 WO claimed
EP-1320523-A2 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Warner-Lambert Company LLC (US) 2003-06-25 EP claimed
CN-1397082-A Transfer film, method for forming metal back layer, and image display device TOSHIBA KK (JP) 2003-02-12 CN claimed
WO-2002024672-A2 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES WARNER-LAMBERT COMPANY LLC (US) 2002-03-28 WO claimed
CN-1155286-A Oxaboroles and salts thereof, and thire use as biocides ZENECA LTD (GB) 1997-07-23 CN claimed
EP-0368085-B1 Process for the preparation of substituted 1,2-naphthoquinone-(2)-diazide-4-sulfonate esters, and their use in a light-sensitive mixture HOECHST AG (DE) 1993-12-08 EP claimed
US-5082932-A PROCESS FOR PREPARING SUBSTITUTED 1,2-NAPHTHOQUINONE-(2)-DIAZIDE-4-SULFONIC ACID ESTERS AND THEIR USE IN A RADIATION-SENSITIVE MIXTURE HOECHST AKTIENGESELLSCHAFT (DE) 1992-01-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071019-A1 NORBORNENE-DERIVED COPOLYMER, MANUFACTURING METHOD THEREOF AND METHOD FOR USING THE SAME NTRK1, PBRM1, RPL8 SLC1A3 4617/4885SLC1A2 4244/4885SLC1A1 4620/4885
US-20050004167-A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases BCAT1, BCAT2, ABAT SLC1A3 29/4885SLC1A2 11/4885SLC1A1 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.